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Mouse embryonic stem cells (ESCs) and the inner
cell mass (ICM)-derived epiblast exhibit naive plurip-
otency. ESC-derived epiblast stem cells (EpiSCs)
and the postimplantation epiblast exhibit primed plu-
ripotency. Although core pluripotency factors are
well-characterized, additional regulators, including
Otx2, recently have been shown to function during
the transition from naive to primed pluripotency.
Here we uncover a role for Otx2 in the control of the
naive pluripotent state. We analyzed Otx2-binding
activity in ESCs and EpiSCs and identified Nanog,
Oct4, and Sox2 as direct targets. To unravel the
Otx2 transcriptional network, we targeted the stron-
gest Otx2-binding site in the Nanog promoter, finding
that this site modulates the size of specific ESC-sub-
type compartments in cultured cells and promotes
Nanog expression in vivo, predisposing ICM differ-
entiation to epiblast. Otx2-mediated Nanog regula-
tion thus contributes to the integrity of the ESC state
and cell lineage specification in preimplantation
development.
INTRODUCTION
In mammals, the progenitors of extraembryonic and embryonic
tissues are established during preimplantation development
(Hermitte and Chazaud, 2014; Martinez Arias et al., 2013;
Schrode et al., 2014; Ohnishi et al., 2014). Differentiation of the
first extraembryonic cell lineage occurs at late morula stage
and generates the trophectoderm (TE) and inner cell mass
(ICM), which in turn differentiate into a second extraembryonic
tissue, the primitive endoderm (prE), and the epiblast from which
all embryonic and adult tissues are generated. Mouse embryonic
stem cells (ESCs) are derived from the ICM and early preimplan-Cell
This is an open access article under the CC BY-Ntation epiblast (Evans and Kaufman, 1981; Martin, 1981; Ros-
sant, 2008; Silva and Smith, 2008; Silva et al., 2009; Nichols
and Smith, 2009; Hanna et al., 2010; Boroviak et al., 2014).
ESCsmay efficiently integrate into host blastocysts and differen-
tiate into all embryonic cell lineages, and their state depends on a
self-maintaining network controlled by core pluripotency factors
Oct4 (also known as Pou5f1), Nanog, Sox2, Klf2/4, and Esrrb, as
well as the LIF-, WNT-, and BMP4-signaling pathways. Indeed,
these factors together define a dynamicmechanism that ensures
indefinite self-renewal and protects ESCs from lineage commit-
ment (Chambers et al., 2007; Niwa et al., 2009; Hanna et al.,
2010; Lanner and Rossant, 2010; Zhang et al., 2010; Lyashenko
et al., 2011; ten Berge et al., 2011; Festuccia et al., 2012).
ESCs grown in serum plus LIF exhibit cell-to-cell reversible dif-
ferences in the expression level and sensitivity to specific tran-
scription factors (TFs) and signaling molecules, which together
maintain the balance between high self-renewal and susceptibil-
ity to differentiation (Hayashi et al., 2008; Silva and Smith, 2008;
Ying et al., 2008; Toyooka et al., 2008; Kalmar et al., 2009; Nich-
ols and Smith, 2011; Smith, 2013; Torres-Padilla and Chambers,
2014). However, when cultured in the presence of LIF and two in-
hibitor molecules (2i), which block glycogen synthase kinase3
(GSK3) andmitogen-activated protein kinaseMEK, ESCs exhibit
homogeneous expression of naive pluripotency TFs and striking
similarity to the preimplantation epiblast (Ying et al., 2008; Nich-
ols and Smith, 2009; Nichols et al., 2009; Silva et al., 2009;
Osorno and Chambers, 2011; ten Berge et al., 2011; Marks
et al., 2012; Boroviak et al., 2014).
Mouse epiblast stem cells (EpiSCs) have been classically
derived from the epiblast of postimplantation pre-grastrula em-
bryos and express Oct4, Sox2, and a low level of Nanog together
with Fgf5, brachyury (T), and other specific markers. EpiSCs
cannot generate chimeric embryos when injected into host blas-
tocysts, and their self-renewal and undifferentiated state depend
on FGF and activin A pathways (Brons et al., 2007; Tesar et al.,
2007; Hanna et al., 2010; Zhang et al., 2010; Lanner andRossant,
2010; Kunath, 2011; Najm et al., 2011; Greber et al., 2010). The
homeodomain TF Otx2 is expressed in both ESCs and EpiSCsReports 15, 2651–2664, June 21, 2016 ª 2016 The Author(s). 2651
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Figure 1. Otx2 Expression in Preimplanta-
tion Mouse Embryos
(A) Immunostaining with Otx2, Nanog, and Cdx2
and with Gata6, Nanog, and Cdx2 was performed
at early morula (8 blastomeres), mid-morula (14–24
blastomeres), and late morula (24–36 blasto-
meres).
(B) Immunostaining with Otx2, Nanog, and Cdx2;
with Gata6, Nanog, and Cdx2; with Otx2, Nanog,
and Oct4; and with Gata4, Nanog, and Cdx2 was
performed at E3.3–E3.5, E3.75–E4, and E4.3–E4.5
to follow Otx2 expression during ICM differentia-
tion into prE (Gata4/6+) and epiblast (Nanog+). In
this context Oct4 is detected in both ICM de-
rivatives and Cdx2 in TE; note that Otx2 is atten-
uated in the ICM at E3.3–E3.5, and, between E3.75
and E4.5, it is detected sporadically in the epiblast
(arrows).
(C) Immunostaining with Otx2, Nanog, and Oct4;
with Otx2, Nanog, and Oct6; and with Gata4,
Nanog, and Oct6 shows that, at E4.5–E4.7, Nanog
is detected in about 50% of epiblast cells and, at
E4.7–E4.9, only in a few epiblast cells and at a low
level. Conversely, Otx2 is strongly upregulated and
at E4.7–E4.9 it is co-expressed with Oct6 in all
epiblast cells. Epi, epiblast; prE, primitive endo-
derm; TE, trophectoderm; ICM, inner cell mass.
Scale bars, 30 mm.as well as in preimplantation and postimplantation embryos
(Acampora et al., 2013). Previous studies have indicated that
Otx2 is required (1) in ESCs cultured in serumwith LIF to antago-
nize naive pluripotency (Acampora et al., 2013), (2) in EpiSCs to
stabilize their state by suppressing mesendoderm into neural
fate switch (Acampora et al., 2013), and, more recently, (3) for
transition of naive into primed pluripotency by recruiting Oct4 at
new enhancers associated to ESC-derived epiblast-like cell
(EpiLC) differentiation (Buecker et al., 2014; Yang et al., 2014).
Here we have investigated the functional relevance of the tran-2652 Cell Reports 15, 2651–2664, June 21, 2016scriptional network controlled by Otx2 in
ESCs, EpiSCs, and in vivo. We show that
loss of the Otx2-binding site in the Nanog
promoter affects, in LIF/FBS growth con-
ditions, the integrity of specific ESC-sub-
type compartments and, in vivo, impairs
the differentiation of the ICM into the
epiblast lineage.
RESULTS
Otx2 Expression in Preimplantation
Development
First we analyzed the Otx2 expression
during preimplantation development in
comparison with that of markers specific
for TE and ICM derivatives corresponding
to Cdx2 (TE), Gata6 (early prE), Gata4 (late
prE), and Nanog (epiblast) (Frankenberg
et al., 2011; Grabarek et al., 2012; Marti-
nez Arias et al., 2013; Hermitte and Cha-zaud, 2014). At early morula (four to eight blastomeres), Otx2
was detected at a low level, while at mid-morula (14–24 blasto-
meres) its expression level was increased and its distribution
shared with Gata6, Nanog, and Cdx2 (Figure 1A). Between em-
bryonic day (E)3.0 (24–36 blastomeres) and E3.5, Otx2 expres-
sion was higher in most of the ICM cells co-expressing Nanog
and Gata6 (Figures 1A and 1B), from E3.5 up to E4.5 Otx2 was
gradually downregulated in the ICM, and from E3.75 up to E4.5
it was almost completely excluded from epiblast and expressed
at a low level in TE (Figure 1B). Between E4.5 and E5.0, Nanog
expression gradually declined, and at E4.7–E4.9 it was almost
undetectable (Figure 1C); in contrast, Otx2 was strongly re-acti-
vated, first in epiblast cells expressing a low level of Nanog and
then in all epiblast cells (Figure 1C).
Interestingly, we found that also Oct6, a marker specific for
primed epiblast (Buecker et al., 2014), was activated between
E4.5 and E4.9 in Nanog or Nanog-Otx2+ epiblast cells (Fig-
ure 1C). Thus, the expression code detected in the epiblast be-
tween E3.75 and E4.5 (Otx2-Oct6-Nanog+) mirrors that
observed at E4.7–E4.9 (Otx2+-Oct6+-Nanog), strongly sug-
gesting that full activation of Otx2 and Oct6 in the epiblast
defines the onset of early primed pluripotency before embryo im-
plantation. This also is supported by overt similarity in Otx2,
Oct6, and Nanog expression profiles between late preimplanta-
tion and early postimplantation epiblasts (see below). Therefore,
these data suggest that Otx2 may play a role in vivo for initiating
the naive-to-primed transition and, in addition, that Otx2 may
have a distinct role at early ICM differentiation stage supporting
the naive TF network.
Identification of Otx2-Binding Sites in ESCs and EpiSCs
Based on previous data (Figure 1) (Acampora et al., 2013;
Buecker et al., 2014; Yang et al., 2014), we investigated the
Otx2 transcriptional network by chromatin immunoprecipitation
sequencing (ChIP-seq) experiments in wild-type (WT) ESCs
and day 4 (d4) EpiSCs, using as negative control ESCs and
EpiSCs lacking Otx2. Total Otx2 peaks and associated genes
are shown (Table S1). In this study, we focused on Otx2 peaks
detected within a 10-kb genomic region located upstream of
the transcription start site (TSS) of the closest gene. We identi-
fied 4,886 putative Otx2 target genes in EpiSCs and 874 in
ESCs; 611 of these were shared by ESCs and EpiSCs (Figure 2A;
Table S2). Then we analyzed the Otx2 peaks identified upstream
of the 611 genes, and we found that 508 peaks were retained in
both ESCs and EpiSCs, 690 were enhanced in EpiSCs, and 225
were enhanced in ESCs (Figure 2B; Table S3). Importantly,
numerous genes involved in pluripotency network control were
identified as Otx2 targets, and among these were Oct4, Nanog,
and Sox2 (Table S4). To validate Otx2 binding to Nanog, Oct4,
and Sox2, we analyzed the genome browser representation of
ChIP-seq profiles and focused the validation assays on the re-
gions covered by Otx2 peaks (pink area in Figures 2C–2E).
Sequence analysis of the genomic region including the Otx2
peaks showed that they contain one or more Otx2 recognition
sequences (Orss) (GGATTA) (Figures 2F–2H) (Buecker et al.,
2014). All ChIP peakswere validated in ESCs and/or EpiSCs (Fig-
ures 2I and 2J), thus indicating that Otx2 may bind the promoter/
enhancer region of core pluripotency factors in both pluripotent
stem cells. Notably, compared to EpiSCs, the diminished Otx2-
binding efficiency detected in ESCs may be partly due to the
reduced percentage of ESCs expressing a high level of Otx2 or
to a decreased Otx2 binding affinity.
Loss of the Otx2-Binding Site 3 in the Nanog Promoter
Region Affects the Integrity of ESC Compartments
To examine the hypothesis that Otx2 may play a role in support
of the naive pluripotency network, we generated an ESC line car-
rying the selective mutagenesis (GGGATTAA into CGACAGTT)of the Otx2-binding site 3 (Obs3), which was located 144 bp
upstream of the Nanog TSS and showed the highest Otx2-
binding enrichment when compared to Obs1 and Obs2 in ChIP
assays (Figures 2I, 2J, and S1A–S1D). First, we analyzed in
NanogDObs3/+ heterozygous ESCs, which exhibited a WT-like
phenotype, whether Otx2 binding to Obs3 was affected by the
Obs3 mutagenesis. To this aim we performed allele-specific
ChIP assays showing selective abrogation of Otx2 binding to
the mutagenized Obs3 (Figure S1E). Conversely, the binding of
Oct4, whose recognition sequence (Oct4bs) is located 36 bp up-
stream of Obs3, appeared similar on both WT and Obs3-
mutated alleles (Figure S1E). Otx2 binding to the mutagenized
Obs3 was abolished in NanogDObs3/DObs3 mutant ESCs and
EpiSCs, whereas binding toObs1 andObs2was unaffected (Fig-
ure 3A). Compared to WT, NanogDObs3/DObs3 ESCs showed flat
morphology and a marked reduction in the number of colonies
uniformly stained with alkaline phosphatase (ALP) (45 ± 13
versus 231 ± 26 of WT) (Figure 3B).
A detailed analysis was performed to assess whether loss of
Obs3affects the identity andsizeof ESC-subtypecompartments.
Previous studies have indicated molecular markers and func-
tional features specific for naive and primed cells (Toyooka
et al., 2008; Silva et al., 2009; Hanna et al., 2010; Lanner andRos-
sant, 2010; Marks et al., 2012; Acampora et al., 2013; Martinez
Arias et al., 2013; Buecker et al., 2014; Torres-Padilla and Cham-
bers, 2014; Kalkan and Smith, 2014). Based on these studies, we
investigated the identity of Obs3 ESC subtypes by analyzing the
combinatorial expression of four markers: Nanog, Otx2, Oct4,
and Oct6. In these experiments, we referred to cells expressing
Nanog, regardless of the protein level, as Nanog+ and to cells ex-
pressing a high or low level of Nanog as NanogH or NanogL,
respectively. Cell counting analysis was performed on cytospun
ESCs. Preliminary immunostaining assays performed with Otx2
and Oct6 and with Oct6 and Nanog showed that, compared to
WT, mutant ESCs exhibited an increased number of Oct6+ cells
and a reduction of those Otx2+ and Nanog+ (Figures 3E and
S2A). Importantly,we found thatOct6+ cellswerecomplementary
to Nanog+ cells both inWT andObs3 ESCs (Figures 3E and S2A).
We next assessed whether the size of ESC-subtype compart-
ments was affected in Obs3 ESCs by counting ESCs after immu-
nostaining with Oct4, Oct6, Nanog, and Otx2 (Figure S2).
Compared to WT, the percentage of Oct4+ cells in Obs3 ESCs
was substantially unaffected, although an increase in the propor-
tion of Oct4L cells was observed (33 ± 5 versus 14 ± 2 ofWT) (Fig-
ures 3C, 3E, andS2A; TableS5). Analysis ofOct6 expression indi-
cated that the Oct6+ subtype was greatly expanded in Obs3
ESCs (43± 7 versus 17± 3 ofWT) (Figures 3C, 3E, andS2A; Table
S5), preferentially in Oct4L cells (Figures 3E and S2A). Analysis of
Nanog and Otx2 co-immunostaining showed that, compared to
WT, the percentage of total cells expressing Nanog was signifi-
cantly reduced in Obs3 ESCs (47 ± 5 versus 79 ± 8 of WT). In
particular, NanogH cells (36 ± 5 versus 52 ± 5 of WT) were dimin-
ished less severely than NanogL cells (10 ± 3 versus 26 ± 3 ofWT)
(Figures 3C and S2A; Table S5). Similarly, the percentage of cells
expressing Otx2 was significantly reduced in Obs3 ESCs (28 ± 5
versus 45 ± 5 of WT) (Figures 3C and S2A; Table S5).
Next, tounambiguouslyassign thesizeand identityofESC-sub-
type compartments, triple immunostaining for Otx2, Nanog, andCell Reports 15, 2651–2664, June 21, 2016 2653
Figure 2. Otx2-Binding Activity in ESCs and EpiSCs Implies Direct Control of Oct4, Nanog, and Sox2
(A) Venn diagram shows the number of genes with Otx2 peaks located within 10 kb upstream of the TSSs in ESCs (red), EpiSCs (green), and in both cell lines
(mustard).
(B) Venn diagram shows the distribution of peaks identified in 611 genes bound by Otx2 in both ESCs (blue) and EpiSCs (yellow); in particular, 508 of these peaks
are shared by ESCs and EpiSCs, 690 are specific for EpiSCs, and 225 are specific for ESCs.
(legend continued on next page)
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Oct6 was performed. Since the Otx2+ subtype may co-express
Nanog or Oct6, we first determined the size of the Otx2+-Oct6
subtype compartment independently of Nanog expression, and
we found that the number of Otx2+-Oct6 cells was remarkably
diminished in Obs3 ESCs (18 ± 3 versus 40 ± 5 of WT) (Figures
3D, 3E, andS2B; Table S5).Wenext analyzed theOct6 subtypes
and found that, compared to WT, in Obs3 ESCs they were all
decreased as a percentage of the total cell number (36 ± 4 versus
48± 5 ofWT for Nanog+-Otx2-Oct6, 13 ± 2 versus 31 ± 4 ofWT
for Nanog+-Otx2+-Oct6, and 5 ± 1 versus 9 ± 1 of WT for
Nanog-Otx2+-Oct6) (Figures 3D, 3E, and S2B; Table S5).
Notably, within the Nanog+-Otx2-Oct6 cells, those exhibiting
NanogH (NanogH-Otx2-Oct6) represented the large majority in
both WT and Obs3 ESCs (33 ± 4 versus 45 ± 4 of WT) (Figures
3D and S2B; Table S5). Consistent with these findings, Oct6+
ESC subtypes were increased in Obs3 ESCs (29 ± 4 versus
9 ± 1 of WT for Nanog-Otx2-Oct6+ and 11 ± 2 versus 7 ± 2 of
WT for Nanog-Otx2+-Oct6+) (Figures 3D and S2B; Table S5).
These findings indicate that, through the combined expression
of Nanog, Otx2, Oct6, and Oct4, we identified in WT ESCs three
major Oct4+ compartments (Figure 3F). The first was Nanog+
(Nanog+-Otx2-Oct6), which accounted for about 48% of total
ESCs and prevalently expressed NanogH. The second was
Oct6+, which accounted for 16% of total ESCs and included
the Nanog-Otx2+-Oct6+ and the Nanog-Otx2-Oct6+ sub-
compartments. The third consisted of Otx2+-Oct6 ESCs, which
accounted for about 40% of total ESCs and included a large
Nanog+-Otx2+-Oct6 sub-compartment and a small Nanog-
Otx2+-Oct6 sub-compartment (Figure 3F). We assigned the
NanogH-Otx2-Oct6-Oct4+ and the Nanog-Otx2+-Oct6+-
Oct4+ expression codes to cells, respectively, with naive-like
and primed-like identities. Between these two extremes, we
made the assumption that the Nanog-Otx2-Oct6+-Oct4+
and the Nanog+-Otx2+-Oct6-Oct4+ expression profiles corre-
sponded to transitional subtypes, respectively, close to the
identity of primed-like and naive-like subtypes, which we called
pre-primed-like and pre-naive-like. In this context, the Nanog-
Otx2+-Oct6-Oct4+ small sub-compartment might represent an
extension of the pre-naive-like sub-compartment (Figure 3F).
Based on this identity code and compared to WT, in Obs3
ESCs the pre-naive-like and pre-primed-like sub-compartments
were remarkably affected and their sizes even inverted; the
primed-like sub-compartment was slightly expanded, and the
naive-like sub-compartment was moderately but significantly
reduced (Figure 3F). Importantly, in the pre-naive-like sub-
compartment of WT ESCs, the expression levels of Nanog and
Otx2were not homogenous andmost of the cells exhibited com-
plementary expression levels (e.g., cells with a high or low level of(C–E) Otx2-binding profiles associated to Nanog (C), Oct4 (D), and Sox2 (E) loci
shown.
(F–H) Schematic representation of the region upstream of the TSSs, showing forN
sequences (Orss) identified within the peak. The horizontal arrows and associated
the Ors position upstream of the TSS is indicated by vertical numbers; the Orss w
Oct4 and 1 to 5 for Sox2.
(I and J) ChIP assays performed on ESCs (I) and d4 EpiSCs (J) for all the Orss identi
to ESCs or EpiSCs null for Otx2.
See also Tables S1, S2, S3, and S4.Otx2 showed, respectively, a low or high level of Nanog) (Fig-
ure 3G). We suggest that, in Otx2+-Oct6 ESCs expressing low
or no Nanog, Otx2 should promote Nanog expression to re-
direct these cells toward naive pluripotency or, alternatively, to
keep them far from pre-primed-like identity switch (Figure 3G).
To further support these data, we also analyzed the expression
of additional markers of the naive and primed states. Compared
to WT, Klf4, Esrrb, Fgf4, and the phosphorylated active form of
the LIF signaling transcriptional mediator Stat3 (p-Stat3) were
all downregulated in Obs3 ESCs (Figures 3H and 3I), while the
expression of epiblast markers, such as Bmp2, T, as well as
p-Erk1,2 and p-Smad1,5,8, respectively the FGF- and BMP-
signaling transducers, was upregulated (Figures 3H and 3I).
Fgf5, a direct target of Otx2 in ESC transition toward EpiLCs
(Buecker et al., 2014), was not induced in mutant ESCs in agree-
ment with the fact that pre-primed-like cells were Otx2.We then
tested the short-term response of Obs3 ESCs to LIF and Fgf.
Compared to WT, mutant ESCs showed a higher and prolonged
response to FGF and reduced activation of LIF signaling (Figures
3J and 3K). These findings support previous data indicating an
expansion of the pre-primed-like and primed-like subtypes and
a contraction of those with pre-naive-like and naive-like identity.
Notably, these experiments (ALP staining, cell counting, and
marker analysis) were consistently reproduced in an indepen-
dently generated Obs3 mutant ESC line (data not shown).
Transcriptome Analysis of Obs3 Mutant ESCs
Previous studies have indicated that genes normally activated in
primed cells are transcribed also in the ESC fraction susceptible
to differentiation (Toyooka et al., 2008). We therefore predicted
that, compared to WT, the transcriptome of Obs3 ESCs would
be more similar to that of primed cells. A scatterplot representa-
tion of gene transcripts differentially expressed (up- and downre-
gulated) inObs3ESCs (NanogDObs3/DObs3ESCs versusWTESCs)
and d4 WT EpiSCs (WT EpiSCs versus WT ESCs) revealed that
mutantESCsshowedanexpressionprofileapproaching theirmo-
lecular identity to that ofWTEpiSCs (Figure 4A; Table S6). Indeed,
Obs3 mutant ESCs exhibited the expression of 626 upregulated
and 395 downregulated genes in common with WT EpiSC-spe-
cific transcripts (Figures 4Band4C;TableS6). A heatmapof these
transcripts (626and395) showed thatmostof themareexpressed
at a level intermediate between WT EpiSCs and WT ESCs (Fig-
ure 4D), while the residual fraction appeared over-activated
(8.8%) or over-repressed (10.4%) when compared toWT EpiSCs
(Figure 4D). RT-PCR validation experiments performed for
selected members of these gene categories showed that they
tended to acquire the expression profile ofWTEpiSCs (Figure 4E)
and that this trend was even more pronounced for genesin ESCs and EpiSCs, with highlighting (pink stripe) of the validated peaks, are
anog (F),Oct4 (G), and Sox2 (H) the extent of the peak and the Otx2 recognition
letters identify the oligonuocleotide pairs employed for ChIP validation assays;
ithin the peaks are sequentially numbered, in particular, 1 to 3 for Nanog and
fiedwithin the peaks. Otx2 binding is reported as folds of enrichment compared
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over-activatedor over-repressed (Figure 4F). Thus, these findings
show that a lack of Obs3 results in the activation of a primed-like
molecular signature correlating with the expansion of the pre-
primed-like and primed-like sub-compartments.
Chimerism of NanogDObs3/DObs3 ESCs Is Severely
Impaired
Then we assayed whether the chimerism of Obs3 ESCs was
impaired. Indeed, if mutant ESCs had significantly expanded the
pre-primed-like subtype, their ability to colonize host blastocysts
should be affected. Therefore, we generated NanogDObs3/DObs3;
R26GFP/+ ESCs, which enabled us to identify GFP+ mutant ESCs
in chimeric embryos.Compared toR26GFP/+ control ESCs (Acam-
pora et al., 2013), the ability of NanogDObs3/DObs3; R26GFP/+ ESCs
to generate chimeric embryos was severely affected (Figures 5A
and 5B). Similarly, a lack of chimerism also was observed with
NanogDObs3/DObs3 ESCs (Figure 5C).
NanogDObs3/DObs3ESCsExhibit an ImprovedResponse to
LIF Deprivation and Fgf2 Stimulation
Next we studied whether Obs3 ESCs can be primed more effi-
ciently by LIF deprivation or Fgf2 addition compared to WT cells.
Indeed,we found that, compared toWT,mutant ESCsexhibited a
higher number of cells co-expressing Otx2 and Oct6 and a com-
plementary marked reduction of Nanog+ cells (Figure 5D). More-
over, compared to WT, in Obs3 ESCs, Fgf5, T, Bmp2, Eomes,
Foxa2, and Mixl1 were activated at a higher level (Figure 5E).
These data indicate that the pre-primed-like cell population
promptly responds toFGF-mediatedactivationof primed factors,
including Otx2, to accomplish its transition into the primed state.
NanogDObs3/DObs3 ESCs Abnormally Respond to
2i/LIF-Mediated Conversion into the Naive State
Then we reverted the question and asked whether Obs3 ESCs
may efficiently be converted into the naive state if cultured inFigure 3. Obs3 Is Required to Maintain Integrity of the ESC State
(A) ChIP assays show that Otx2 binding to Obs3 is abolished in Obs3 mutant ES
(B) Graphic representation shows that the number of Obs3 ESC colonies uniform
(C and D) Cell-counting data show the percentage of total cells expressing Oct4, N
and Oct6 (D) (*p = 0.001, **p < 0.001, and ***p < 0.001).
(E) Immunohistochemistry experiments showing in WT and NanogDObs3/DObs3 ESC
and Oct6, and Otx2 and Oct6. In some immunohistochemistry experiments cells
(F andG) The ESC state is characterized by cell heterogeneity and the co-existenc
ESCs cultured in LIF/FBS, three major Oct4+ ESC compartments: the first is Nano
by NanogH-Otx2-Oct6 naive-like cells (45 ± 4) (dark blue); the second is Oct6+,
Nanog-Otx2-Oct6+ pre-primed-like (9 ± 1) (pale blue) and the Nanog-Otx2+-O
for 40% of total cells, and includes a large Nanog+-Otx2+-Oct6 pre-naive-like (3
compartment (light blue). Loss of Obs3 generates a remarkable size re-organizatio
which, compared to WT, are respectively expanded and contracted. (G) Our d
expressing high Otx2 and low or no Nanog, Obs3 is required for Otx2 to re-activat
naive-like and Nanog-Otx2+-Oct6 ESC subtypes into pre-primed-like subtype
indicated in (F); the presumptive expression level for Nanog and Otx2 is shown i
(H and I) Western blot (H) and RT-PCR assays (I) show that, compared to WT, Ob
increased expression of Oct6; a moderate increase is observed also for epibl
unaffected (I). The assessment of LIF-, FGF-, and BMP-signaling pathways show
reduction of p-Stat3 (H).
(J and K) Compared to WT, Obs3 mutant ESCs show a higher and prolonged res
efficient response to LIF (K).
See also Figures S1 and S2 and Table S5.N2B27 supplemented with LIF and 2i molecules. Obs3 ESCs
were analyzed at passage 5 (P5), after transfer to the LIF/2i condi-
tion. Compared to WT, mutant ESCs generated fewer and much
smaller Nanog+-Oct4+ pluripotent colonies and, unexpectedly,
numerous Sox1+-Tuj1+ neuronal cells (Figure 5F). Further pas-
sages in LIF/2i medium, however, restored in mutant ESCs a
phenotype very similar to that ofWT ESCs, likely due to the selec-
tive expansion of the initially small fraction of naive cells. In addi-
tion, bothWT andmutant ESCs lackedOtx2 andOct6 expression
in 2i/LIF (Figure 5F). However, when returned to FBS/LIF, WT
and mutant ESCs restored expression of Otx2 and Oct6
(Figure 5F). Thus, Obs3 ESCs resist for several passages to effi-
cient conversion into naive pluripotency, and transiently a large
fraction of them, possibly those with pre-primed-like identity, dif-
ferentiates into neural cells. Thus, these and previous findings
suggest that Obs3 mutant ESCs are a mixture of naive ESCs
and EpiSCs.
Obs3 EpiSCs Exhibit Abnormalities in Proliferation,
Identity, and Mesendoderm Differentiation
Since Otx2 showed robust binding to Obs3 in EpiSCs, we stud-
ied whether also the generation and identity of Obs3 EpiSC
colonies were affected. Compared to WT, d4 mutant EpiSC col-
onies were remarkably larger in size and exhibited sharp borders
and compact morphology (Figure 6A). Analysis of apoptotic
cell death and mitotic index showed a substantial decrease of
active Caspase3+ (act-Casp3) cells and a 2-fold increase of
phospho-Histone3+ (p-H3) cells (Figures 6A and 6B; Table S7),
suggesting that reduced apoptosis and contemporary hyper-
proliferation may be responsible for increased size of mutant
EpiSC colonies. Furthermore, compared to WT, in mutant
EpiSCs, Nanog was downregulated, Otx2 and Oct6 were upre-
gulated, Oct4 and Fgf5 were unaffected, and the expression of
mesendoderm markers (e.g., T, Foxa2, Chordin [Chd], Mixl1,
Gata4, andGata6) was diminished (Figures 6C–6E). In particular,Cs and EpiSCs, while the binding to Obs1 and Obs2 is unaffected.
ly expressing ALP is diminished (***p < 0.001).
anog, Otx2, and Oct6 (C) or expressing different combinations of Otx2, Nanog,
s the expression of Otx2 and Nanog, Nanog and Oct4, Oct6 and Oct4, Nanog
also are stained with DAPI. Scale bar, 100 mm.
e of different cell subtypes (F). Through ourmarker analysis, we identified, inWT
g+-Otx2-Oct6, accounts for 48% of total ESCs, and is prevalently composed
accounts for 16% of total cells, and includes two small sub-compartments, the
ct6+ primed-like (7 ± 1) (light pale blue); and the third is Otx2+-Oct6, accounts
1 ± 4) sub-compartment (blue) and a small Nanog-Otx2+-Oct6 (9 ± 1) sub-
n primarily affecting the pre-primed-like and pre-naive-like sub-compartments,
ata suggest that, in the Otx2+-Oct6 compartment and in particular in ESCs
e/enhance Nanog expression. This event should prevent identity switch of pre-
and promote progression toward the naive-like identity. The color codes are
n magenta and orange, respectively (G).
s3 ESCs exhibit reduced levels of Otx2, Nanog, Oct4, Klf4, Esrrb, and Fgf4 and
ast markers, such as T, Bmp2, Eomes, and Mixl1, while Fgf5 expression is
s that Obs3 ESCs exhibit increased levels of p-Erk1,2 and p-Smad1,5,8 and a
ponse to Fgf2 addition after brief starvation in 5% KSR (J) and, instead, a less
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Figure 4. The Transcriptome of Obs3 Mutant ESCs Exhibits a Molecular Signature Approaching that of Primed EpiSCs
(A) Scatterplot shows the number of upregulated (x axis) and downregulated (y axis) genes, as deduced by comparingWT EpiSCs (black square) versusWT ESCs
(black dot) and NanogDObs3/DObs3 ESCs (green dot) versus WT ESCs.
(B and C) Venn diagrams show the number of genes upregulated (B) and downregulated (C) in Obs3 ESCs and WT EpiSCs.
(D) Heatmap shows the upregulated (626) and downregulated (395) genes shared by WT EpiSCs and NanogDObs3/DObs3 ESCs.
(E and F) Validation assayswere performed onWT andObs3 ESCs and d4 EpiSCs for selected genes upregulated or downregulated at intermediate level (E) or for
those over-activated or over-repressed (F).
See also Table S6.immunohistochemistry assays showed that T and Foxa2 were
expressed in restricted subregions of EpiSC colonies (Figure 6C)
or often not expressed at all. Analysis of FGF, BMP, and WNT2658 Cell Reports 15, 2651–2664, June 21, 2016pathways showed that the levels of p-Erk1,2; p-Smad1,5,8;
phospho-b-catenin; and active-b-catenin were unaffected (Fig-
ure 6D). Therefore, these data suggest that Obs3-dependent
Figure 5. NanogDObs3/DObs3 ESCs Exhibit
Impaired Chimerism and Enhanced
Response to Fgf2
(A–C) Embryos injected with NanogDObs3/DObs3;
R26GFP/+ mutant and R26GFP/+ control ESCs are
analyzed at E12.5 for detection of GFP+ cells (A);
the arrows in (B) point to sporadic small groups of
GFP+ cells; impaired chimerism is evident alsowith
NanogDObs3/DObs3 ESCs (C).
(D and E) Immunohistochemistry (D) and RT-
PCR assays (E) were performed on WT and
NanogDObs3/DObs3 ESCs, cultured for 12 hr in 15%
KSR + LIF, in 5% KSR without LIF, or in 5% KSR
supplemented with Fgf2 or PD, to assess the dis-
tribution of Nanog, Otx2, and Oct6 (D) and the
expression of Fgf5, T, Bmp2, Eomes, Foxa2, and
Mixl1 (E).
(F) Immunohistochemistry assays performed on
WT and Obs3 ESCs cultured in LIF/2i show that
Obs3 ESCs exhibit (at P5) small ESC colonies ex-
pressing Nanog and Oct4 and many Sox1+-Tuj1+
neural cells; however, at P12, WT and Obs3 ESCs
are very similar. When re-plated in LIF/FBS, WT
and Obs3 ESCs revert to their original identities.
Scale bars, 100 mm.functions also are required in EpiSCs to control their identity,
proliferation, and differentiation.
Otx2 Binding to Obs3 Is Required for the Differentiation
of ICM-Derived Epiblast Lineage
Next we investigated whether the Otx2 binding to Obs3 is
required also in vivo to support the naive pluripotency net-Cell Rwork controlling epiblast specification.
NanogDObs3/DObs3 mutant mice were
healthy and fertile, but, compared to WT,
the number of mice per litter was reduced
by about 50% (Figure S3A). This reduc-
tion also was observed at E12.5 and
E6.5; at E4 the number of embryos per
litter was yet diminished by about 25%,
and only at E2.5 was it close to that of
WT (Figure S3A). This suggested two
temporal windows of preimplantation
lethality: the first before E4 and the sec-
ond between E4 and implantation. Immu-
nohistochemistry experiments between
E5.5 and E6.7, with markers for extraem-
bryonic ectoderm (Oct6), epiblast (Otx2,
Oct4, Nanog, and Oct6), extraembryonic
endoderm derivatives (Gata4, Foxa2,
and Otx2), and primitive streak (T and
Foxa2), showed no evident abnor-
malities in Obs3 mutants (Figure S3B).
Conversely, at early/mid-morula stage,
Obs3 mutants exhibited a heterogeneous
phenotype: 24% of mutants were similar
to WT embryos; 13% showed degenerat-
ing blastomeres with the loss of Nanog,Otx2, and Gata6 expression; and 62% exhibited either a severe
loss (28%) or a less drastic but evident reduction (34%) of cells
expressing a high level of Nanog (Figures 7A and S4A; Table
S8). Apparently, the expression of Otx2 and Gata6 was unaf-
fected (Figures 7A and S4A).
In early blastocysts Nanog was downregulated in many ICM
cells (Figure 7B). At E3.75–E4, 71% of mutant blastocystseports 15, 2651–2664, June 21, 2016 2659
Figure 6. NanogDObs3/DObs3 EpiSCs Exhibit
Abnormalities in Proliferation, Apoptosis,
and Mesendoderm Differentiation
(A and B) Morphology inspection, immunohisto-
chemistry assays with act-Casp3 and p-H3 (A),
and cell counting of p-H3+ and act-Casp3+ cells (B)
are shown (*p = 0.001 and **p < 0.001).
(C–E) Immunohistochemistry (C), western blot (D),
and RT-PCR (E) experiments reveal that,
compared to WT, in Obs3 EpiSCs Nanog is
downregulated; Otx2 and Oct6 are upregulated
(C and D); T, Foxa2, Chd, Mixl1, Gata6, and Gata4
mesendoderm markers are diminished (C–E);
and Oct4, Fgf5, p-Erk1,2, act-b-cat, p-b-cat, and
p-Smad1,5,8 are unmodified (D). Scale bars,
100 mm.
See also Table S7.exhibited abnormal expression of Nanog and Gata4 (Figures 7C
and S4B; Table S8). Indeed, while the expression of Oct4, Cdx2,
and Otx2 was unaffected, Nanog was detected in few epiblast
cells andGata4 expanded to Nanog presumptive epiblast cells.
At E4.7–E4.9, a total of 42%of Obs3mutants showed severe ab-
normalities in molecular identity and/or morphology. Indeed,
Gata4 was detected in many cells distributed in the epiblast re-
gion, while Otx2 and Oct6 were expressed in a remarkably
diminished number of epiblast cells complementary to those
Gata4+ (Figures 7D and S4C). These Otx2+-Oct6+ cells should
correspond to the progeny of the few Nanog+ epiblast cells
detected at E3.75–E4. As for the rest of mutant embryos,
31% of them exhibited a moderate reduction in the number of2660 Cell Reports 15, 2651–2664, June 21, 2016Otx2+ cells and a corresponding increase
of Gata4+ cells, and 25% of them dis-
played a fairly normal morphology (Fig-
ure S4C). Based on these findings, we
hypothesized that Otx2-null mutants
should exhibit abnormalities in common
with NanogDObs3/DObs3 embryos. In this
context, although Otx2/ embryos
exhibit moderate de-repression of Nanog
in postimplantation epiblast (Acampora
et al., 2013), little is known about their pre-
implantation phenotype. We found that,
at E3.75–E4 and E4.7–E4.9, about 50%
of Otx2/ embryos showed abnormal-
ities very similar to those detected in
Obs3 mutants (Figure S5). At E3.75–E4,
Otx2/ mutants with normal expression
of Gata4 exhibited an apparently unaf-
fected expression of Nanog (data not
shown); instead at E4.7–E4.9, compared
to WT, five of nine mutants showed upre-
gulation of Nanog in most epiblast cells
(Figure S5B). This abnormality was never
observed in Obs3 mutants.
Collectively, our data indicate that Otx2
contributes (1) atmid- to latemorula stage
to program subsequent differentiation ofthe ICM into epiblast through Obs3-mediated control of Nanog
expression, and (2) between E4 and E4.7 to efficiently downregu-
late Nanog. However, the phenotype variability of Obs3 mutants
suggests the existence of compensatory mechanism(s) ensuring
embryo survival.
DISCUSSION
We have investigated the role of the Otx2 transcriptional
network in the control of the ESC state. We identified Oct4,
Sox2, and Nanog as direct targets of Otx2, and we studied the
functional relevance of the Otx2 binding to the proximal pro-
moter region of Nanog. Loss of Obs3 generates a new ESC
Figure 7. Obs3 Mutant Embryos Exhibit Se-
vere Impairment in Differentiation of ICM-
Derived Epiblast Lineage
(A) Immunostaining with Otx2, Nanog, and Cdx2
and with Gata6, Nanog, and Cdx2 shows that,
at mid-morula (14–24 blastomeres), most of
NanogDObs3/DObs3 mutants strongly attenuate
Nanog expression, while the expression of Gata6,
Otx2, and Cdx2 appears unchanged. A fraction of
Obs3 mutants exhibits a very strong phenotype
with loss of all markers except occasional staining
with Cdx2 (arrows).
(B) Immunostaining with Gata6, Nanog, and Cdx2
shows that, at E3.3–E3.5, mutant embryos confirm
the reduced expression of Nanog.
(C) Immunostaining with Otx2, Nanog, and Oct4
and with Gata4, Nanog, and Cdx2 shows that, at
E3.75–E4 in most of Obs3 mutants, Nanog is de-
tected in a reduced number of Oct4+ epiblast cells
and Gata4 is expanded to most of Nanog pre-
sumptive epiblast cells.
(D) Immunostaining with Otx2, Nanog, and Oct4
and with Gata4, Otx2, and Oct6 shows that, at
E4.7–E4.9, the majority of NanogDObs3/DObs3 em-
bryos, although abnormal in morphology and
Gata4 expression, activate Otx2 and Oct6 in the
residual Gata4-Oct4+ epiblast cells. Nanog is
sporadically expressed only in some Otx2+ cells.
(E) Schematic representation integrating our data
(in red) with those previously reported (in black)
shows that, during ICM differentiation of prE and
epiblast, loss of Obs3 affects Nanog expression in
ICM precursors of epiblast (dashed arrow); a
reduced level of Nanog results in decreased effi-
ciency to repress Gata4/6 factors (dashed sup-
pression symbol) and consequent epiblast into prE
identity switch. Abbreviations are as in previous
Figures. Scale bars, 30 mm.
See also Figures S3–S5 and Table S8.steady state characterized by a size re-distribution of ESC-sub-
type compartments; overall this new steady state exhibits
increased similarities to primed pluripotent cells, although a
naive component is retained. We also show that in vivo loss of
Obs3 causes downregulation of Nanog expression at morula
stage and abnormal differentiation of the ICM-derived epiblast
lineage.Cell ROtx2 Controls the Identity and
Number of Specific ESC Subtypes
by Binding to the Nanog Promoter
The mechanism that controls pluripo-
tency in naive and primed stem cells has
allowed the identification of regulatory
networks that instruct pluripotent stem
cells on how to establish and maintain
their state and how to direct cell lineage
decisions or transition between different
pluripotent states (Kalmar et al., 2009;
Hanna et al., 2010; Lanner and Rossant,
2010; Spitz and Furlong, 2012; Kalkan
and Smith, 2014; Torres-Padilla andChambers, 2014). In this study we have investigated the role of
the Otx2 binding to the Nanog promoter, a specific branch
of the Otx2 transcriptional network. We have shown that, in
LIF/FBS growth conditions, loss of this specific branch affects
the integrity of ESC-subtype compartments. Indeed, Obs3
mutant ESCs exhibit severe abnormalities mainly affecting
the size of two specific ESC subtypes, which we called theeports 15, 2651–2664, June 21, 2016 2661
pre-naive-like (Nanog+-Otx2+-Oct6-Oct4+) and the pre-
primed-like (Nanog-Otx2-Oct6+-Oct4+) ESCs. Compared to
WT, the number of pre-naive-like ESCs was diminished while
that of pre-primed-like cells remarkably expanded. To a lesser
extent, also the naive-like and the primed-like subtypes were
respectively reduced and expanded (Figure 3F).
We suggest that abnormalities detected in Obs3 mutant ESCs
should originate prevalently in the pre-naive-like sub-compart-
ment, which exhibits graded distribution of complementary
levels of Otx2 andNanog, and in the Nanog-Otx2+-Oct6 unas-
signed sub-compartment (Figure 3G). We propose that Otx2
contributes to activating/sustaining Nanog expression, in cells
co-expressing high Otx2 and low or no Nanog, to allow re-direc-
tioning of cell identity toward the naive subtype (Figure 3G). It
remains to be clarified whether a high level of Nanogmay subse-
quently repress Otx2 to allow full progression into the naive-like
subtype; in this context, our data indicate that in ESCs Nanog
may efficiently bind the Otx2 promoter region (data not shown).
In summary, our data uncover a mechanism that contributes to
maintaining the integrity of the ESC steady state by preventing
an identity switch of the pre-naive-like into the pre-primed-like
subtype. This mechanism also may contribute to the metastable
condition of ESCs grown in LIF/FBS by regulating cell heteroge-
neity among transitional sub-compartments of pluripotency, and
it is dispensable in LIF/2i culture conditions where naive pluripo-
tency becomes unimodal and Otx2 expression suppressed
(Hayashi et al., 2008; Kalmar et al., 2009; Silva et al., 2009; Fad-
dah et al., 2013; Torres-Padilla and Chambers, 2014; Ohnishi
et al., 2014). Interestingly, Obs3 mutant ESCs do not exhibit an
irreversible and progressive conversion into the pre-primed-
like subtype, rather they establish a new steady-state equilibrium
characterized by a new size representation of internal subtype
compartments (Figure 3F), whichmay imply the existence of pro-
gressive states of pluripotency.
Otx2, Nanog, and Oct6 Expression in Preimplantation
Embryos Identifies Three Stage-Specific Expression
Profiles of the Epiblast
In preimplantation embryos at mid- to late morula and early blas-
tocyst stages, Otx2 is detected at a high level prevalently in
Nanog+ cells of the ICM; from E3.5, Otx2 expression is gradually
downregulated in the epiblast where, fromE3.7 to E4.5, it is virtu-
ally absent. Conversely, from E4.5 onward, Nanog is downregu-
lated and Otx2 together with Oct6 rapidly activated in the
epiblast, which exhibits overt similarity with that of early postim-
plantation embryos. This suggests that transition of naive into
primed pluripotency may occur before implantation. Further-
more, together with previous studies (Silva and Smith, 2008;
Silva et al., 2009; Najm et al., 2011; Acampora et al., 2013; Mar-
tinez Arias et al., 2013; Torres-Padilla and Chambers, 2014;
Boroviak et al., 2014), our data suggest three stage-specific
expression profiles of the epiblast: the first, between E3.5 and
E4.5, is dominated by a high level of Nanog and a low level of
Otx2 and exhibits ground-state naive pluripotency and marked
similarity to ESCs cultured in LIF/2i; the second, between E4.5
and E4.7, is characterized by contemporary and frequently com-
plementary expression of Nanog and Otx2 and resembles the
identity of ESCs cultured in LIF/FBS; and the third, between2662 Cell Reports 15, 2651–2664, June 21, 2016E4.7 and implantation, is characterized by a low level or no
expression of Nanog and high levels of Otx2 and Oct6, may
correspond to the initial primed state, and is markedly similar
to that of early EpiLCs.
Obs3-Dependent Control of Nanog Expression by Otx2
Modulates ICM Differentiation of the Epiblast
Previous studies indicated that mutual antagonism between
Nanog and Gata6 is an essential aspect of ICM differentiation
into epiblast and prE (Kwon et al., 2008; Frankenberg et al.,
2011; Grabarek et al., 2012; Martinez Arias et al., 2013; Ohnishi
et al., 2014; Hermitte and Chazaud, 2014; Bessonnard et al.,
2014; Schrode et al., 2014). In these studies, the loss of Nanog
results in an expansion of the Gata6+ prE lineage at the expense
of the epiblast. However, in these studies, the factor(s) required
to activate/maintain Nanog expression before and during ICM
differentiation remained elusive. Our data show that, in the ma-
jority (>70%) of mutant embryos, Otx2 is required through
Obs3 to activate/sustain Nanog expression at mid- to late
morula stage to predispose ICM for differentiation of the epiblast
cell lineage. Coherently, about 50% of Otx2-null mutants exhibit
similar abnormalities. Therefore, the loss of Obs3 or Otx2 results
in early downregulation of Nanog and inefficient antagonism of
Gata6/4 expression with consequent identity switch of ICM-
derived epiblast precursors into prE (Figure 7E). Thus, the
Obs3-dependent control of Nanog expression by Otx2 may
trigger early cell lineage specification in mammalian develop-
ment. Furthermore, since the analysis of Otx2/ embryos indi-
cates that after E4 Otx2 is required also to downregulate Nanog
in the epiblast, together these data suggest that, during blasto-
cyst development, Otx2 and Nanog impart complementary and
inter-dependent instructions controlling initial specification of
naive epiblast and, subsequently, its transition to primed plurip-
otency. However, the finding that Obs3 mutants do not exhibit a
fully penetrant phenotype suggests the existence of a possible
backup system partially compensating for the loss of Obs3.
EXPERIMENTAL PROCEDURES
Generation of Obs3 Mutant ESCs and Mouse Strain
The Obs3 mutation was introduced in the NanogDObs3-targeting vector by
PCR-mediated mutagenesis (Figure S1A). Targeting of the construct was
done into the E14Tg2a ESC line (Figures S1B and S1C). One NanogDObs3/+
ESC clone was either injected into C57BL6 blastocysts to establish a mutant
mouse colony or re-targeted to obtain a NanogDObs3/DObs3 ESC line. Genotyp-
ing was performed with allele-specific primers (Figure S1D; Table S9). Target-
ing of the GFP gene in the Rosa26 locus of NanogDObs3/DObs3 ESCs was
performed as reported (Acampora et al., 2013). Animals were handled in
accordance with the authorization 1196/2015-PR released by the Italian
Ministry of Health.
Cell Culture Experiments and ALP Assays
E14Tg2aWT andObs3mutant ESCswere grown inGlasgowminimal essential
medium (GMEM) plus fetal bovine serum (FBS) (HyClone) and LIF (Millipore).
As for the experiments involving 2i, ESCs grown in FBS/LIF were plated in
N2B27 medium supplemented with LIF, MEK1/2 inhibitor PD325901 (PD),
andGSK3 inhibitor CHIR99021 (CHIR) (both fromCalbiochem) (LIF/2i medium)
(Buecker et al., 2014). These cells were referred to as P1 and were propagated
every 3 days by accutase treatment up to P12. EpiSCs were induced from
ESCs as previously described (Brons et al., 2007; Acampora et al., 2013)
and analyzed at d4. Response of WT and NanogDObs3/DObs3 ESCs to LIF and
Fgf2 starvation/re-stimulation was assayed as previously described (Zhang
et al., 2010; Acampora et al., 2013). ALP assays were performed as previously
described (Acampora et al., 2013). The number of ESC colonies and SD were
calculated in four independent assays, and p value was determined by using
the one-tailed Student’s t test.
RT-PCR and Western Blotting
RT-PCRs were performed in non-saturating conditions using primers and
cycles listed in Table S9. Western blots were probed with antibodies as previ-
ously described (Acampora et al., 2013), with the addition of rabbit antibodies
against p-b-catenin (1:750) and bcat (1:1,000) (Cell Signaling Technology) and
mouse antibodies against Oct6 (1:600) and act-b-catenin (1:750) (Millipore).
Cell Counting, Chimerism Experiments, and Immunohistochemistry
Detailed descriptions are provided in the Supplemental Experimental
Procedures.
ChIP-Seq Experiments, ChIP Assays, and ChIP-Seq Data Analysis
Detailed descriptions are provided in the Supplemental Experimental
Procedures.
RNA-Seq Experiments, Analysis of RNA-Seq Data, Heatmap
Representation, and RNA-Seq Validation Assays
Detailed descriptions are provided in the Supplemental Experimental
Procedures.
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